Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparative Immunogenicity of Hepatitis B Vaccine Schedules in Adults
NCT06515938Completed
- Sponsor
- Suzhou Wujiang Pharmaceutical
- Start
- Jan 2013
- Primary completion
- Jun 2014
- Modality
- Split/Subunit Vaccines, Recombinant Protein Vaccines
- Countries
- 1
01
Overview
Randomised, open-label trial of Hepatitis B vaccine in hepatitis B (HBV) (4 arms), sponsored by Suzhou Wujiang Pharmaceutical. Primary endpoint: Anti-Hepatitis B Surface Antibody. Started Jan 2013; status: completed.
02
Drugs
Hepatitis B vaccine
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT06515938.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06515938.